Home » Clinical Trials » Search Clinical Trials

Therapeutic Areas: Oncology

Soft Tissue Sarcoma Clinical Trials

A listing of Soft Tissue Sarcoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35243

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Arizona

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of MM-310

Tucson Arizona

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

California

Stanford University Medical Center
Palo Alto California 94304

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Sarcoma Oncology Research Center
Santa Monica California 90403

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Duarte California 91010

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Los Angeles California 90033

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of Pembrolizumab to evaluate Soft Tissue Sarcoma or Bone Sarcoma

San Francisco California 94115

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Santa Monica California 90404

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Santa Monica California 90403

A clinical trial seeking patients for a research study for the treatment of Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma

Colorado

University of Colorado Cancer Center
Aurora Colorado 80045

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Connecticut

New Haven Connecticut 06520

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

District of Columbia

MedStar Washington Hospital Center
Washington District of Columbia 20010

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

UPDATED

Washington District of Columbia 20010

Patients are needed to participate in a clinical research study of Pembrolizumab to evaluate Soft Tissue Sarcoma or Bone Sarcoma

Florida

Mayo Clinic of Jacksonville
Jacksonville Florida 32224

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Jacksonville Florida 32224

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Jacksonville Florida 32224

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

UPDATED

Jacksonville Florida 32224

Patients are needed to participate in a clinical research study of Pembrolizumab to evaluate Soft Tissue Sarcoma or Bone Sarcoma

Miami Florida 33136

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Miami Florida 33136

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Tampa Florida 33612

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

UPDATED

Tampa Florida 33612

Patients are needed to participate in a clinical research study of Pembrolizumab to evaluate Soft Tissue Sarcoma or Bone Sarcoma

Georgia

Georgia Cancer Specialists
Sandy Springs Georgia 30342

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Atlanta Georgia 30342

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Illinois

Northwestern University Feinburg School of Medicine
Chicago Illinois 60611

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Iowa

University of Iowa Hospital and Clinics
Iowa City Iowa 52242

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Iowa City Iowa

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Radiotherapy for the treatment of Soft Tissue Sarcoma

Kansas

Overland Park Kansas 66210

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

Maryland

Baltimore Maryland 21287

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Baltimore Maryland 21218

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

UPDATED

Baltimore Maryland 21201

Patients are needed to participate in a clinical research study of Combination Radiation, Immunotherapy, Surgery to evaluate Soft Tissue Sarcoma

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Boston Massachusetts 02215

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Boston Massachusetts 02215

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Michigan

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

UPDATED

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study of Pembrolizumab to evaluate Soft Tissue Sarcoma or Bone Sarcoma

Detroit Michigan 48201

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Minnesota

Mayo Clinic Rochester
Rochester Minnesota 10029

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Rochester Minnesota 55905

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Rochester Minnesota 55902

Patients are needed to participate in a clinical research study of MM-310

UPDATED

Rochester Minnesota 55905

Patients are needed to participate in a clinical research study of Pembrolizumab to evaluate Soft Tissue Sarcoma or Bone Sarcoma

Missouri

Washington University in St. Louis
St. Louis Missouri 63110

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

St. Louis Missouri 63110

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

St. Louis Missouri 63110

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

St. Louis Missouri 63130

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

UPDATED

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study of Pembrolizumab to evaluate Soft Tissue Sarcoma or Bone Sarcoma

Nebraska

Omaha Nebraska 68114

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

New York

Tisch Cancer Institute
New York New York 10029

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)